Harmony Biosciences
HRMY
HRMY
218 hedge funds and large institutions have $1.51B invested in Harmony Biosciences in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 75 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less capital invested
Capital invested by funds: $1.64B → $1.51B (-$131M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
47% less call options, than puts
Call options by funds: $1.47M | Put options by funds: $2.78M
Holders
218
Holding in Top 10
5
Calls
$1.47M
Puts
$2.78M
Top Buyers
| 1 | +$8.92M | |
| 2 | +$7.37M | |
| 3 | +$7.33M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$7.18M |
| 5 |
Renaissance Technologies
New York
|
+$6.51M |
Top Sellers
| 1 | -$6.41M | |
| 2 | -$6.01M | |
| 3 | -$4.46M | |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$4.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.28M |